Key Players
Competitive Landscape
Lactase market includes global enzyme manufacturers and specialty suppliers offering products for dairy, food, infant formula, supplements and laboratory use. Major companies are focusing on enzyme activity, different pH conditions, stable formulations and production capacity in order to cater the growing demand. Combination of Novozymes and Chr. Hansen into Novonesis, Kerry's lactase acquisition and movement of the Maxilact platform into dsm-firmenich has changed the competitive structure.
Regulatory status and production testing are major factors affecting supplier changes. Food manufacturers requires a preparation suitable for the intended use and production result showing the required lactose level. Kerry's expanded capacity is supporting industrial supply, whereas the FDA record for the Advanced Enzyme Technologies fungal lactase shows the separate approval and qualification required for a new preparation. Suppliers providing documented enzyme performance and application support are expected to increase their customer base.
Company developments mapped to drivers, trends and opportunities (2026-2036)
| Development | Driver | Trend | Opportunity |
|---|---|---|---|
| April 2024: Kerry completed the acquisition of part of the Novonesis lactase enzyme business. | Processors seek reliable lactase scale and broader formulation support. | Consolidation is combining enzyme IP, manufacturing and applications under larger platforms. | Use acquired lactase capability to support customer trials and commercial production. |
| May 2023: Firmenich completed its merger with DSM, placing the Maxilact lineage inside dsm-firmenich. | Buyers increasingly evaluate lactase alongside wider dairy formulation needs. | Bioscience portfolios are being combined with taste and nutrition capabilities. | Expand lactase use in dairy reformulation and sugar-reduction applications. |
| March 2024: Biocatalysts added large-scale freeze-drying at its Cardiff site. | Customers require stable enzyme formats matched to specific manufacturing workflows. | Flexible downstream formulation is becoming part of specialty-enzyme differentiation. | Offer customized dry enzyme formats for premix, storage and dosing applications. |
Other profiled participants have different application focus. Amano Enzyme Inc. and Novact Corporation offer digestive lactase products, whereas Merck KGaA supplies laboratory lactase through Sigma-Aldrich. Advanced Enzyme Technologies Limited addresses human nutrition as well as dairy processing applications.
Source: FMI analysis based on the public sources cited in Research Sources and Bibliography.
Increasing demand for validated enzyme performance, flexible formulation and dependable supply is expected to influence the competition in lactase market over the forecast period.
How are profiled companies positioned within the lactase market?
Kerry Group plc, Novozymes A/S and the legacy Koninklijke DSM N.V. platform have industrial dairy lactase capabilities. Advanced Enzyme Technologies Limited and Biocatalysts Ltd. address processing and formulation needs, whereas Amano Enzyme Inc. and Novact Corporation have digestive-enzyme products.
What qualification or purchasing requirements matter when buyers compare suppliers?
Buyers compare enzyme source, process pH, dosage, regulatory status and residual-lactose result before selecting a supplier. Application support and production scale also affects whether a successful trial is converted into regular purchasing.
Which profiled companies show differentiated product or application capability?
Novozymes A/S is represented through Novonesis products for dairy and infant formula. The legacy Koninklijke DSM N.V. platform includes acidic and neutral Maxilact enzymes, whereas Advanced Enzyme Technologies Limited offers lactase for human nutrition and whey processing.
How does geographic reach differ among the profiled companies?
Kerry Group plc has global enzyme supply, while Novonesis operates application and manufacturing sites across regions. Advanced Enzyme Technologies Limited has operations in Asia, America and Europe, and Biocatalysts Ltd. manufactures enzymes in the UK.
Representative Company Overview
| Company | Positioning | Verified Development |
|---|---|---|
| Advanced Enzyme Technologies Limited | Fungal lactase in human nutrition plus a documented dairy lactase for whey processing. | As of September 8, 2026, FDA GRAS Notice 1329 listed the company as notifier for an Aspergillus oryzae lactase for lactose-free milk and lactase-treated whey; FDA’s letter remained pending. |
| Amano Enzyme Inc. | Specialty-enzyme supplier with Lactase DS products documented for lactose-intolerance applications. | On July 25, 2024, Amano announced an expansion of its Elgin manufacturing site in Illinois. Construction had started May 28 and the addition was planned to add 29,827 square feet across warehouse, production and office areas. |
| DuPont de Nemours Inc. | Legacy nutrition and biosciences participant whose current standalone lactase capability requires careful qualification. | On February 1, 2021, DuPont completed the transaction that merged its Nutrition & Biosciences business with IFF and reorganized DuPont around other reporting segments. |
Research Methodology
Company mapping includes documented lactase products, manufacturing activities, application support, regulatory records and corporate transactions. The ratings do not represent the market share and unavailable public information is left unscored.
